P291 NEW COMPUTER SOFTWARE TO ASSESS SEVERITY OF MEDIAL-TYPE OSTEOARTHRITIS OF KNEE ON MRI  by Sasho, T. et al.
Osteoarthritis and Cartilage Vol. 14, Supplement B S159
of 0.3125 x 0.3125 x 1.5 mm; 3D T1-rho weighted images
with a 3D SPGR sequence, T1-rho magnetization preparation
(TSL=0/10/40/80 ms; spin-lock frequency = 500 Hz; ∼13 min),
and spatial resolution of 0.625 x 0.625 x 3 mm; and images
to compute 2D T2 maps with a fat-suppressed multi-echo SE
sequence (TR = 2500 ms; TE=15/30/45/60 ms; ∼12 min), and
same spatial resolution as the T1-rho scans.
Femoral and acetabular cartilage was segmented semi-
automatically as a composite from the WE-SPGR images (∼17
slices). For the morphological parameters, the cartilage shape
was interpolated to get isotropic voxels, and its volume and 3D
thickness were computed. T2 and T1-rho maps were computed
pixel-by-pixel by mono-exponential fittings, and the cartilage
ROI were mapped to them to compute mean relaxation times.
Femoral heads were segmented partially and semi-automatically,
and spheres of maximum radii were fitted to them. The process
was repeated twice and coefficients of variation (CV) were com-
puted to measure the reproducibility of the whole technique
(acquisition to analysis).
Results: Table 1, which summarizes the results of this study, is
consistent with mean values previously reported for thickness,
volume, and T1-rho for hip cartilage. T2 values are similar to
those previously reported for knee cartilage, and they were not
significantly correlated to T1-rho (p>.0.23; Fig. 1). Reproducibility
as determined by CV was 1.25% for T1rho and 7.5% for T2.
Table 1. MRI derived morphological, relaxometry and geometrical parameters
for the hip joint at 3T (n=5)
Mean CV
Cartilage thickness 3.12 mm 2.19%
Cartilage volume 6.26 ml 3.50%
Cartilage T1p 39.30 ms 1.25%
Cartilage T2 34.02 ms 7.5%
Femoral head radius 23.07 mm 0.49%
Fig. 1. T1p and T2 relaxation times of hip cartilage at 3T.
Conclusions: This study shows the feasibility of in vivo quantifi-
cation of T2 maps for the hip cartilage, and also demonstrates
that in vivo MRI morphological, relaxometry and geometrical
characterization of the hip joint is highly reproducible. A possible
explanation of the higher T2 variation could be related to the
magic angle effect, since patient positioning varies from scan to
scan. Current work is focused on parallel imaging techniques to
reduce acquisition times, as well as on improving patient posi-
tioning. Results indicate that these techniques may be applied
to patients with OA of the hip to investigate the relevance of the
studied parameters.
Acknowledgment: Belinda Li, GE Medical Systems, for provid-
ing the WE-SPGR sequence.
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Purpose: To evaluate the longitudinal occurrence and persis-
tence of bone marrow edema (BME) in early osteoarthritis (OA)
of the knee.
Methods: 23 patients (8 female; 15 male; mean age 55.5±10.3
years) were scanned with a 1.5T MRI imaging unit (sagittal fat
suppressed intermediate-weighted FSE; 4mm section thickness,
1mm intersection gap, 256x192 matrix, 120 FOV). Images were
obtained in 23 patients at 2 timepoints (TP) and in 12 patients
at 3 TPs. Images were evaluated by two readers independently;
discrepancies in image grading were reviewed and evaluated in
consensus. A four point image grading scale was used (absence
of BME to severe BME). Four main anatomical regions were
evaluated (medial femur, lateral femur, medial tibia, lateral tibia)
and they were subcategorized in anterior, central and posterior
region. Statistical methods included summary statistics, one-way
analysis of variance (ANOVA) test and Kruskal Wallis test to
evaluate the change in BME over the three time points.
Results: 105 BME in 23 patients were found in all three TPs in
52 different locations of the knee joint. In 16 patients the BME
was consistent at the same location over time. In 7 locations the
BME became larger. In 6 areas smaller and in 16 locations it
could not be detected on follow up MRIs. In one case the BME
was smaller at TP 2 but increased at TP3. In 8 cases BME could
be detected only at the last timepoint. There was no statistically
significant difference in mean or median BME scores over the
three time points.
Conclusions: BME is not a static phenomenon. It changes over
time. Correlation to physical activity, biomechanical loading, and
inflammatory parameters should be evaluated.
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Purpose: The purpose of this study is to make new computer
software that can measure the irregularity of contour of medial
femoral condyle (MFC) of subchondral bone on MRI automati-
cally and establish the reliable index that can show the objective
severity of OA
Methods: Fifty five knees with medial-type OA were involved
(mean age: 72.8 years old). None of them had received surgical
treatment beforehand. Their Lysholm score was recorded. All
patients underwent MRI of the knees on a 1.5-T unit (Signa,
GE medical systems) proton-weighted sagittal image were used
for this study. Parameters for the proton-weighted sequence was
2000/16 ms (TR/TE). The field of view was 14*14cm, matrix
512X256, number of excitations 2, and slice thickness 3mm
without an interslice gap. Irregularity of MFC was calculated
by newly developed computer software. This software is pro-
grammed in MATLAB6.5. This software can use DICOM data
directly. 1) At first, images to be assessed are selected. At this
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step, images that represent the center of medial compartment
are selected. 2) Then, the image is converted into black-and-
white image. Threshold between black and white is determined
by the software. 3) Lastly, the contour of MFC is extracted and
four parameters are calculated automatically: a) the average
thickness of the subchondral bone plate (ATS: tentative units),
the ratio of the length of upper surface and the lower surface of
the subchondral bone plate (RUL), c) average squared thickness
of the subchondral bone plate (ASTS) and d) standard deviation
of the thickness of the subchondral bone (SDS). The more se-
vere the irregularity becomes the larger ATS, RUL, ASTS and
SDS become. Correlation between those parameters and clinical
score were analyzed using Pearson’s correlation coefficient.
Results: The data of four parameters were as follows. ATS: 3.34
to 16.42 (ave. 7.01), RUL: 0.980 to 1.536 (ave. 1.165), ASTS:
14.63 to 382.21(ave. 69.70) and SDS: 1.258 to 7.991 (ave.
3.504). ATS, RUL, ASTS and SDS were statistically significant
correlation with Lysholm score (p<0.05).
Conclusions: We have concluded that 1) ATS, RUL, ASTS and
SDS could serve as an objective index that indicating disease
severity of OA; 2) pathological state of subchondral bone plate
was one of the biggest factors to determine the severity of OA;
3) ATS, RUL, ASTS and SDS reflected the pathological state of
subchondral bone area; and 4) ATS, RUL, ASTS and SDS could
be a objective determinant when selecting treatment option.
Non-Surgical Treatment of OA
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Purpose: Osteophytes (OST), which develop through endochon-
dral ossification often at sites of adjacent cartilage loss, are key
features of osteoarthritis (OA). OST in the spine are accompa-
nied by OST in peripheral joints and agents that affect OST in
the spine may potentially affect OST elsewhere in the body. We
evaluated the effect of the bisphosphonate alendronate (ALN)
on the progression of radiographic spinal OST in a secondary
analysis of the Fracture Intervention Trial (FIT).
Methods: FIT was a large (n=6463) randomized placebo-
controlled trial evaluating the effectiveness of ALN at 5 mg/d
(1st 2 years) followed by 10 mg/d thereafter vs placebo (PBO)
over 3-4 years (3 for those with prevalent vertebral fractures
(VtFx), 4 for those without one) in preventing osteoporotic frac-
tures in postmenopausal women with prevalent VtFx or low bone
mass. In a random sample of 200 participants, stratified by age
(<65 vs. ≥65) and presence of baseline VtFx, we read baseline
and follow-up lateral spine x-rays for anterior OST (scored 0-3 on
the superior and inferior aspects of each vertebral body) in the
thoracic (T4-T12) and lumbar (L1-L5) spine (ICC for lumbar=0.88
and for thoracic=0.97), blinded to treatment. We calculated the
sum of OST scores from T4 to L5 at baseline and follow-up. We
evaluated the mean difference in change from baseline to fol-
lowup in the summary OST score between treatment arms using
linear regression and performed separate analyses in which we
additionally adjusted for age, BMI, presence of baseline VtFx,
presence of incident VtFx, baseline kyphosis score, and pres-
ence of diabetes at baseline.
Results: The baseline characteristics of the participants were
similar in ALN and PBO arms (Table 1). The mean change in
summary OST score was significantly less in the ALN group com-
Table 1. Baseline Characteristics
Variable ALN (n=84) PBO (n=116)
Age [mean ± SD (range)] 68.5 ± 6.1 (55-79) 66.1 ± 6.4 (55-80)
Age ≥65 [n (%)] 39 (46.3) 55 (47.1)
BMI [mean ± SD] 24.8 ± 4.2 25.3 ± 3.9
Diabetes [n (%)] 4 (4.8) 5 (4.4)
Baseline Vertebral Fracture [n (%)] 50 (59.5) 64 (55.2)
Incident Vertebral Fracture [n (%)] 5 (6.0) 9 (7.8)
Baseline summary OST score
[mean ± SD (range)] 15.7 ± 9.2 (1-52) 15.5 ± 8.8 (2-49)
Table 2. Change in summary OST score
ALN (n=84) PBO (n=116)
Unadjusted change in summary
OST score [mean ± SE] 3.1 ± 0.4 4.8 ± 0.5 P=0.02
Adjusted* change in summary
OST score [mean ± SE] 3.2 ± 0.4 4.8 ± 0.5 P=0.03
*Adjusted for age, BMI, diabetes, baseline vertebral fracture, incident vertebral
fracture, baseline kyphosis score.
pared to the PBO group (p=0.02) (Table 2), indicating that OST
progression was less in the ALN group. The results remained the
same after multivariable adjustment for potential confounders.
There was no evidence of interaction between treatment as-
signment and presence of baseline or incident VtFx (p=0.3 and
0.7 respectively) suggesting that the prevention of VtFx did not
cause the inhibition of OST growth.
Conclusions: In this pilot study of the effect of ALN vs PBO
on progression of spinal OST from a randomized clinical trial in
older women, ALN was associated with less OST progression
than PBO. This suggests a role for bisphosphonates in altering
the process of OST formation which may be due to direct effects
on endochondral ossification processes or on OA.
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Purpose: Intra-articular injection of hyaluronan (HA)-based vis-
cosupplements is a local therapy for the treatment of pain due to
osteoarthritis. HA is a major component of synovial fluid that pro-
vides shock absorption, joint lubrication and cartilage protection
to the joint. The purpose of these studies was to compare the
physical and histological properties of two crosslinked HA-based
visocosupplements. One of them is NASHA (non-animal stabi-
lized hyaluronic acid) which is an epoxy crosslinked product, and
the other is hylan G-F 20, a divinyl sulfone crosslinked product.
The physical properties including rheology and dilution durability
of the products were evaluated. The biological reactivity of the
products was also evaluated using a muscle implant test.
Methods: The rheological properties of the products, such as
modulus, phase angle, rupture stress and viscosity were as-
sessed by the oscillation and viscometry tests of a control stress
rheometer. For the dilution durability test, the products were di-
luted with buffered saline and the rheological properties were
determined for each dilution. The maximum dilution at which the
percent phase angle increase continued to be ≤ 50% was de-
fined as the product’s dilution durability. The biological reactivity
of the two products was compared with high density polyethylene
(HDPE) as a control. The response to each product was eval-
uated macroscopically and microscopically in a rabbit muscle
implant model at 7 days and 4 weeks after implantation.
Results: NASHA showed a much higher modulus, but much
lower rupture stress (Table 1) than hylan G-F 20. Results sug-
